Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -11.38%152.57M | -11.38%152.57M | 33.20%267.64M | -1.96%156.91M | 19.22%210.72M | 13.44%172.16M | 13.44%172.16M | 22.00%200.93M | 16.80%160.05M | -5.18%176.75M |
-Cash and cash equivalents | -11.92%109.41M | -11.92%109.41M | 21.85%244.83M | -37.80%99.56M | 19.22%210.72M | 45.43%124.21M | 45.43%124.21M | 22.00%200.93M | 16.80%160.05M | -5.18%176.75M |
-Restricted cash and investments | -9.97%43.17M | -9.97%43.17M | --22.82M | --57.36M | ---- | -27.73%47.95M | -27.73%47.95M | ---- | ---- | ---- |
Receivables | 5.11%62.04M | 5.11%62.04M | 15.65%64.37M | 18.60%62.75M | 31.20%61.45M | 31.01%59.02M | 31.01%59.02M | 30.75%55.66M | 36.33%52.91M | 25.54%46.84M |
-Accounts receivable | 5.11%62.04M | 5.11%62.04M | 15.65%64.37M | 18.60%62.75M | 31.20%61.45M | 31.01%59.02M | 31.01%59.02M | 30.75%55.66M | 36.33%52.91M | 25.54%46.84M |
Net loan | -1.33%6.78B | -1.33%6.78B | -1.15%6.78B | -0.86%6.74B | -1.23%6.78B | -0.40%6.87B | -0.40%6.87B | -0.85%6.86B | 1.08%6.79B | 4.50%6.87B |
-Gross loan | -1.31%6.81B | -1.31%6.81B | -1.32%6.81B | -0.80%6.78B | -1.09%6.82B | -0.40%6.9B | -0.40%6.9B | -0.72%6.9B | 1.15%6.83B | 4.46%6.9B |
-Allowance for loans and lease losses | 2.60%42.18M | 2.60%42.18M | -23.48%38.16M | 6.82%48.3M | 21.58%47.09M | 1.65%41.11M | 1.65%41.11M | 20.84%49.87M | 14.70%45.22M | 3.46%38.73M |
-Unearned income | 5.29%10.1M | 5.29%10.1M | 3.51%9.38M | -5.31%8.37M | -7.19%8.34M | 6.43%9.59M | 6.43%9.59M | 1.48%9.06M | 11.40%8.84M | 35.29%8.98M |
Securities and investments | 99.96%1.49B | 99.96%1.49B | 88.90%1.46B | 46.79%1.38B | 12.30%994.32M | 18.24%747.64M | 18.24%747.64M | -13.78%770.62M | 1.19%942.89M | -3.13%885.45M |
-Held to maturity securities | -31.23%46.99M | -31.23%46.99M | -2.66%66.99M | -7.94%67.51M | -7.59%67.94M | -1.20%68.33M | -1.20%68.33M | -6.90%68.81M | -1.05%73.33M | -0.94%73.52M |
-Short term investments | 113.16%1.45B | 113.16%1.45B | 97.87%1.39B | 51.41%1.32B | 14.10%926.38M | 20.63%679.31M | 20.63%679.31M | -14.40%701.81M | 1.39%869.56M | -3.33%811.93M |
Federal home loan bank stock | 22.63%38.1M | 22.63%38.1M | -25.28%32.75M | 28.10%46.33M | -35.93%24.85M | -32.23%31.07M | -32.23%31.07M | -29.87%43.82M | -27.69%36.17M | 14.42%38.78M |
Bank owned life insurance | 2.18%218.17M | 2.18%218.17M | 1.34%217.2M | 1.30%215.94M | 0.22%214.72M | 0.18%213.52M | 0.18%213.52M | 0.93%214.32M | 0.92%213.16M | 1.12%214.24M |
Net PPE | 4.64%63.65M | 4.64%63.65M | 1.00%63.33M | 3.69%66.06M | -9.56%57.73M | -6.47%60.83M | -6.47%60.83M | -6.77%62.71M | -7.63%63.71M | -10.38%63.84M |
-Gross PPE | 6.70%133.18M | 6.70%133.18M | 1.00%63.33M | 3.69%66.06M | -9.56%57.73M | 1.42%124.82M | 1.42%124.82M | -6.77%62.71M | -7.63%63.71M | -10.38%63.84M |
-Accumulated depreciation | -8.66%-69.53M | -8.66%-69.53M | ---- | ---- | ---- | -10.26%-63.99M | -10.26%-63.99M | ---- | ---- | ---- |
Goodwill and other intangible assets | -2.16%18.76M | -2.16%18.76M | -2.23%18.86M | -2.30%18.96M | -2.37%19.06M | -2.44%19.17M | -2.44%19.17M | -2.51%19.29M | -2.58%19.41M | -2.64%19.53M |
-Goodwill | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M | 0.00%17.64M |
-Other intangible assets | -26.94%1.12M | -26.94%1.12M | -26.11%1.22M | -25.27%1.32M | -24.48%1.43M | -23.80%1.54M | -23.80%1.54M | -23.10%1.65M | -22.48%1.77M | -21.86%1.89M |
Other assets | -41.45%214.91M | -41.45%214.91M | 8.49%383.08M | 114.24%410.82M | 163.45%443.28M | 3.14%367.05M | 3.14%367.05M | 97.16%353.09M | 19.19%191.75M | 34.44%168.26M |
Total assets | 5.88%9.04B | 5.88%9.04B | 8.20%9.28B | 7.36%9.1B | 3.87%8.81B | 1.36%8.54B | 1.36%8.54B | 0.23%8.58B | 1.61%8.47B | 3.79%8.48B |
Liabilities | ||||||||||
Total deposits | 5.34%7.18B | 5.34%7.18B | 13.33%7.57B | 2.72%6.91B | 7.71%7.25B | 5.09%6.82B | 5.09%6.82B | 9.08%6.68B | 4.93%6.72B | 4.36%6.73B |
Long term debt and capital lease obligation | 9.11%962.5M | 9.11%962.5M | -14.61%891.56M | 51.26%1.36B | -23.87%710.15M | -19.74%882.1M | -19.74%882.1M | -35.60%1.04B | -20.89%901.8M | 0.37%932.86M |
-Long term debt | 8.89%916.05M | 8.89%916.05M | -15.47%846.12M | 53.55%1.32B | -24.34%671.47M | -20.10%841.28M | -20.10%841.28M | -36.36%1B | -21.31%857.4M | 1.18%887.51M |
-Long term capital lease obligation | 13.77%46.44M | 13.77%46.44M | 5.50%45.44M | 6.94%47.49M | -14.73%38.67M | -11.50%40.82M | -11.50%40.82M | -10.89%43.07M | -11.81%44.4M | -13.27%45.35M |
Other liabilities | 1.75%173M | 1.75%173M | -17.81%150.04M | -9.08%161.01M | 25.54%174.14M | 5.38%170.04M | 5.38%170.04M | 30.18%182.56M | 46.07%177.09M | 24.17%138.71M |
Total liabilities | 5.68%8.31B | 5.68%8.31B | 8.93%8.61B | 8.07%8.43B | 4.25%8.14B | 1.57%7.87B | 1.57%7.87B | 0.27%7.91B | 1.74%7.8B | 4.16%7.81B |
Shareholders'equity | ||||||||||
Share capital | 13.49%387K | 13.49%387K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K |
-common stock | 13.49%387K | 13.49%387K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K | 0.00%341K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 23.49%326.67M | 23.49%326.67M | -1.21%261.27M | -1.20%260.59M | -0.94%260.41M | 0.08%264.53M | 0.08%264.53M | 0.28%264.49M | 0.34%263.74M | 0.40%262.88M |
Retained earnings | -10.49%492M | -10.49%492M | -0.54%547.71M | -0.45%545.35M | 0.14%546.53M | 0.40%549.68M | 0.40%549.68M | 1.25%550.68M | 3.91%547.81M | 7.23%545.79M |
Less: Treasury stock | -4.16%101.66M | -4.16%101.66M | -3.60%101.63M | -2.81%101.63M | 3.97%101.64M | 7.65%106.07M | 7.65%106.07M | 15.89%105.43M | 18.37%104.57M | 22.45%97.76M |
Gains losses not affecting retained earnings | 118.45%7.13M | 118.45%7.13M | 0.32%-40.8M | -9.15%-39.32M | 5.21%-35.82M | -5.93%-38.65M | -5.93%-38.65M | 11.58%-40.93M | -15.21%-36.02M | -143.70%-37.78M |
Total stockholders'equity | 8.17%724.54M | 8.17%724.54M | -0.34%666.89M | -0.89%665.32M | -0.54%669.83M | -1.08%669.84M | -1.08%669.84M | -0.24%669.14M | 0.07%671.3M | -0.35%673.46M |
Total equity | 8.17%724.54M | 8.17%724.54M | -0.34%666.89M | -0.89%665.32M | -0.54%669.83M | -1.08%669.84M | -1.08%669.84M | -0.24%669.14M | 0.07%671.3M | -0.35%673.46M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |